Verrica Pharmaceuticals Inc (NASDAQ:VRCA)

11.81
Delayed Data
As of Jan 20
 +0.64 / +5.76%
Today’s Change
6.02
Today|||52-Week Range
17.60
+2.61%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Verrica Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 25.00 and a low estimate of 17.00. The median estimate represents a +69.35% increase from the last price of 11.81.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Verrica Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.40
Sales
$0.00
Reporting Date
Mar 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.76%
 
 
 
 
 
 
Growthannually -40.93%
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.